Brand Name | Status | Last Update |
---|---|---|
allevia | unapproved drug other | 2025-02-27 |
choline c 11 | New Drug Application | 2024-12-17 |
zyrexal | unapproved drug other | 2020-02-10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | — | 1 | — | — | — | 1 |
Hodgkin disease | D006689 | — | C81 | — | 1 | — | — | — | 1 |
Transitional cell carcinoma | D002295 | — | — | — | 1 | — | — | — | 1 |
Invasive hydatidiform mole | D002820 | — | D39.2 | — | 1 | — | — | — | 1 |
Drug common name | Edrecolomab |
INN | edrecolomab |
Description | Edrecolomab (mouse mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108955 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB13375 |
UNII ID | 0KYI9U9FSJ (ChemIDplus, GSRS) |